Loading…
Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers
ABSTRACT Introduction/Aims It is imperative to screen asymptomatic carriers of transthyretin (TTR) mutations to initiate treatment early. The protocol for repeated electrodiagnostic (EDX) assessments over time lacks standardization. Our aim was to report the electrophysiological evolution of a cohor...
Saved in:
Published in: | Muscle & nerve 2025-02, Vol.71 (2), p.208-215 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c3348-e7be3ba3c54f819fd2579d3c4df1409a91fc41cd8cca34dbb53978f3155676f93 |
container_end_page | 215 |
container_issue | 2 |
container_start_page | 208 |
container_title | Muscle & nerve |
container_volume | 71 |
creator | Berard, Nicolas Verschueren, Annie Fortanier, Etienne Grapperon, Aude‐Marie Kouton, Ludivine Rebouh, Hadia Gallard, Julien Salort‐Campana, Emmanuelle Attarian, Shahram Delmont, Emilien |
description | ABSTRACT
Introduction/Aims
It is imperative to screen asymptomatic carriers of transthyretin (TTR) mutations to initiate treatment early. The protocol for repeated electrodiagnostic (EDX) assessments over time lacks standardization. Our aim was to report the electrophysiological evolution of a cohort of asymptomatic carriers and to determine which biomarkers were most sensitive to change.
Methods
We performed a retrospective review of medical records of asymptomatic carriers identified by screening families with amyloid neuropathy. Carriers who underwent two EDX assessments with a minimum 1‐year interval between studies were selected. EDX included analysis of median, ulnar, tibial, fibular and sural nerves, motor unit number index (MUNIX), electrochemical skin conductance, sympathetic skin response, and heart rate variability on deep breathing. Measurements were compared at first and second examinations.
Results
Twenty‐three carriers were included with a median age of 49 years (interquartile range 37–58). Median time between examinations was 3 years (2–4). Compound muscle and sensory nerve action potential (CMAP and SNAP) amplitudes, nerve conduction velocities, autonomic small fiber testing and MUNIX remained stable except for motor distal latency of the median nerve (+0.07 ms/year) and CMAP duration of the ulnar (+0.10 ms/year) and fibular (+0.12 ms/year) nerves. The CMAP duration of the ulnar nerve was the most sensitive biomarker to change when performed within 10 years preceding the age of the youngest case in the family, with a standardized response mean of 0.91.
Discussion
Nerve conduction parameters remain relatively stable in asymptomatic TTR carriers. Changes can only be detected using multimodal and extensive electrophysiological tests. |
doi_str_mv | 10.1002/mus.28318 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11708451</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3152517341</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3348-e7be3ba3c54f819fd2579d3c4df1409a91fc41cd8cca34dbb53978f3155676f93</originalsourceid><addsrcrecordid>eNp1kV1rFDEUhoModlu98A_IgDf2YtuczcckV1KW-gFdemEL3oVMJtlNmUnWJFOZf2_q1qKCVwfOeXh4Dy9CbwCfAcar83HKZytBQDxDC8CyXVImxXO0wEDFkhP57Qgd53yHMQbB25foiEjOBWd4ga4vB2tKivvdnH0c4tYbPTSbGHyJyYdtE11zkedxX-KoizfNTdIhl92cbPGh2UylbmNo1jolb1N-hV44PWT7-nGeoNuPlzfrz8ur609f1hdXS0NIDWXbzpJOE8OoEyBdv2Kt7ImhvQOKpZbgDAXTC2M0oX3XMSJb4QgwxlvuJDlBHw7e_dSNtjc2lKQHtU9-1GlWUXv19yX4ndrGewXQYkEZVMP7R0OK3yebixp9NnYYdLBxyooA5ZxTYLyi7_5B7-KUQv2vUmzFoCX0QXh6oEyKOSfrntIAVg89qdqT-tVTZd_-Gf-J_F1MBc4PwA8_2Pn_JrW5_XpQ_gSg8p8u</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3152517341</pqid></control><display><type>article</type><title>Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Berard, Nicolas ; Verschueren, Annie ; Fortanier, Etienne ; Grapperon, Aude‐Marie ; Kouton, Ludivine ; Rebouh, Hadia ; Gallard, Julien ; Salort‐Campana, Emmanuelle ; Attarian, Shahram ; Delmont, Emilien</creator><creatorcontrib>Berard, Nicolas ; Verschueren, Annie ; Fortanier, Etienne ; Grapperon, Aude‐Marie ; Kouton, Ludivine ; Rebouh, Hadia ; Gallard, Julien ; Salort‐Campana, Emmanuelle ; Attarian, Shahram ; Delmont, Emilien</creatorcontrib><description>ABSTRACT
Introduction/Aims
It is imperative to screen asymptomatic carriers of transthyretin (TTR) mutations to initiate treatment early. The protocol for repeated electrodiagnostic (EDX) assessments over time lacks standardization. Our aim was to report the electrophysiological evolution of a cohort of asymptomatic carriers and to determine which biomarkers were most sensitive to change.
Methods
We performed a retrospective review of medical records of asymptomatic carriers identified by screening families with amyloid neuropathy. Carriers who underwent two EDX assessments with a minimum 1‐year interval between studies were selected. EDX included analysis of median, ulnar, tibial, fibular and sural nerves, motor unit number index (MUNIX), electrochemical skin conductance, sympathetic skin response, and heart rate variability on deep breathing. Measurements were compared at first and second examinations.
Results
Twenty‐three carriers were included with a median age of 49 years (interquartile range 37–58). Median time between examinations was 3 years (2–4). Compound muscle and sensory nerve action potential (CMAP and SNAP) amplitudes, nerve conduction velocities, autonomic small fiber testing and MUNIX remained stable except for motor distal latency of the median nerve (+0.07 ms/year) and CMAP duration of the ulnar (+0.10 ms/year) and fibular (+0.12 ms/year) nerves. The CMAP duration of the ulnar nerve was the most sensitive biomarker to change when performed within 10 years preceding the age of the youngest case in the family, with a standardized response mean of 0.91.
Discussion
Nerve conduction parameters remain relatively stable in asymptomatic TTR carriers. Changes can only be detected using multimodal and extensive electrophysiological tests.</description><identifier>ISSN: 0148-639X</identifier><identifier>ISSN: 1097-4598</identifier><identifier>EISSN: 1097-4598</identifier><identifier>DOI: 10.1002/mus.28318</identifier><identifier>PMID: 39668650</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Action potential ; Action Potentials - physiology ; Adult ; Amyloid Neuropathies, Familial - diagnosis ; Amyloid Neuropathies, Familial - genetics ; Amyloid Neuropathies, Familial - physiopathology ; Assessments ; Asymptomatic ; asymptomatic carriers ; Autonomic nervous system ; Biomarkers ; Clinical ; Electrochemistry ; Electrodiagnosis - methods ; electrophysiological monitoring ; familial amyloid polyneuropathy ; Female ; Heart rate ; Heterozygote ; Humans ; Latency ; Male ; Median nerve ; Medical records ; Middle Aged ; Mutation ; Nerve conduction ; Neural Conduction - physiology ; Neuropathy ; Parameter sensitivity ; Prealbumin - genetics ; Retrospective Studies ; Sensory neurons ; Skin ; small fiber testing ; Standardization ; Sympathetic nervous system ; Transthyretin</subject><ispartof>Muscle & nerve, 2025-02, Vol.71 (2), p.208-215</ispartof><rights>2024 The Author(s). published by Wiley Periodicals LLC.</rights><rights>2024 The Author(s). Muscle & Nerve published by Wiley Periodicals LLC.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3348-e7be3ba3c54f819fd2579d3c4df1409a91fc41cd8cca34dbb53978f3155676f93</cites><orcidid>0000-0002-5591-2774</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39668650$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berard, Nicolas</creatorcontrib><creatorcontrib>Verschueren, Annie</creatorcontrib><creatorcontrib>Fortanier, Etienne</creatorcontrib><creatorcontrib>Grapperon, Aude‐Marie</creatorcontrib><creatorcontrib>Kouton, Ludivine</creatorcontrib><creatorcontrib>Rebouh, Hadia</creatorcontrib><creatorcontrib>Gallard, Julien</creatorcontrib><creatorcontrib>Salort‐Campana, Emmanuelle</creatorcontrib><creatorcontrib>Attarian, Shahram</creatorcontrib><creatorcontrib>Delmont, Emilien</creatorcontrib><title>Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers</title><title>Muscle & nerve</title><addtitle>Muscle Nerve</addtitle><description>ABSTRACT
Introduction/Aims
It is imperative to screen asymptomatic carriers of transthyretin (TTR) mutations to initiate treatment early. The protocol for repeated electrodiagnostic (EDX) assessments over time lacks standardization. Our aim was to report the electrophysiological evolution of a cohort of asymptomatic carriers and to determine which biomarkers were most sensitive to change.
Methods
We performed a retrospective review of medical records of asymptomatic carriers identified by screening families with amyloid neuropathy. Carriers who underwent two EDX assessments with a minimum 1‐year interval between studies were selected. EDX included analysis of median, ulnar, tibial, fibular and sural nerves, motor unit number index (MUNIX), electrochemical skin conductance, sympathetic skin response, and heart rate variability on deep breathing. Measurements were compared at first and second examinations.
Results
Twenty‐three carriers were included with a median age of 49 years (interquartile range 37–58). Median time between examinations was 3 years (2–4). Compound muscle and sensory nerve action potential (CMAP and SNAP) amplitudes, nerve conduction velocities, autonomic small fiber testing and MUNIX remained stable except for motor distal latency of the median nerve (+0.07 ms/year) and CMAP duration of the ulnar (+0.10 ms/year) and fibular (+0.12 ms/year) nerves. The CMAP duration of the ulnar nerve was the most sensitive biomarker to change when performed within 10 years preceding the age of the youngest case in the family, with a standardized response mean of 0.91.
Discussion
Nerve conduction parameters remain relatively stable in asymptomatic TTR carriers. Changes can only be detected using multimodal and extensive electrophysiological tests.</description><subject>Action potential</subject><subject>Action Potentials - physiology</subject><subject>Adult</subject><subject>Amyloid Neuropathies, Familial - diagnosis</subject><subject>Amyloid Neuropathies, Familial - genetics</subject><subject>Amyloid Neuropathies, Familial - physiopathology</subject><subject>Assessments</subject><subject>Asymptomatic</subject><subject>asymptomatic carriers</subject><subject>Autonomic nervous system</subject><subject>Biomarkers</subject><subject>Clinical</subject><subject>Electrochemistry</subject><subject>Electrodiagnosis - methods</subject><subject>electrophysiological monitoring</subject><subject>familial amyloid polyneuropathy</subject><subject>Female</subject><subject>Heart rate</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Latency</subject><subject>Male</subject><subject>Median nerve</subject><subject>Medical records</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Nerve conduction</subject><subject>Neural Conduction - physiology</subject><subject>Neuropathy</subject><subject>Parameter sensitivity</subject><subject>Prealbumin - genetics</subject><subject>Retrospective Studies</subject><subject>Sensory neurons</subject><subject>Skin</subject><subject>small fiber testing</subject><subject>Standardization</subject><subject>Sympathetic nervous system</subject><subject>Transthyretin</subject><issn>0148-639X</issn><issn>1097-4598</issn><issn>1097-4598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kV1rFDEUhoModlu98A_IgDf2YtuczcckV1KW-gFdemEL3oVMJtlNmUnWJFOZf2_q1qKCVwfOeXh4Dy9CbwCfAcar83HKZytBQDxDC8CyXVImxXO0wEDFkhP57Qgd53yHMQbB25foiEjOBWd4ga4vB2tKivvdnH0c4tYbPTSbGHyJyYdtE11zkedxX-KoizfNTdIhl92cbPGh2UylbmNo1jolb1N-hV44PWT7-nGeoNuPlzfrz8ur609f1hdXS0NIDWXbzpJOE8OoEyBdv2Kt7ImhvQOKpZbgDAXTC2M0oX3XMSJb4QgwxlvuJDlBHw7e_dSNtjc2lKQHtU9-1GlWUXv19yX4ndrGewXQYkEZVMP7R0OK3yebixp9NnYYdLBxyooA5ZxTYLyi7_5B7-KUQv2vUmzFoCX0QXh6oEyKOSfrntIAVg89qdqT-tVTZd_-Gf-J_F1MBc4PwA8_2Pn_JrW5_XpQ_gSg8p8u</recordid><startdate>202502</startdate><enddate>202502</enddate><creator>Berard, Nicolas</creator><creator>Verschueren, Annie</creator><creator>Fortanier, Etienne</creator><creator>Grapperon, Aude‐Marie</creator><creator>Kouton, Ludivine</creator><creator>Rebouh, Hadia</creator><creator>Gallard, Julien</creator><creator>Salort‐Campana, Emmanuelle</creator><creator>Attarian, Shahram</creator><creator>Delmont, Emilien</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5591-2774</orcidid></search><sort><creationdate>202502</creationdate><title>Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers</title><author>Berard, Nicolas ; Verschueren, Annie ; Fortanier, Etienne ; Grapperon, Aude‐Marie ; Kouton, Ludivine ; Rebouh, Hadia ; Gallard, Julien ; Salort‐Campana, Emmanuelle ; Attarian, Shahram ; Delmont, Emilien</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3348-e7be3ba3c54f819fd2579d3c4df1409a91fc41cd8cca34dbb53978f3155676f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Action potential</topic><topic>Action Potentials - physiology</topic><topic>Adult</topic><topic>Amyloid Neuropathies, Familial - diagnosis</topic><topic>Amyloid Neuropathies, Familial - genetics</topic><topic>Amyloid Neuropathies, Familial - physiopathology</topic><topic>Assessments</topic><topic>Asymptomatic</topic><topic>asymptomatic carriers</topic><topic>Autonomic nervous system</topic><topic>Biomarkers</topic><topic>Clinical</topic><topic>Electrochemistry</topic><topic>Electrodiagnosis - methods</topic><topic>electrophysiological monitoring</topic><topic>familial amyloid polyneuropathy</topic><topic>Female</topic><topic>Heart rate</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Latency</topic><topic>Male</topic><topic>Median nerve</topic><topic>Medical records</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Nerve conduction</topic><topic>Neural Conduction - physiology</topic><topic>Neuropathy</topic><topic>Parameter sensitivity</topic><topic>Prealbumin - genetics</topic><topic>Retrospective Studies</topic><topic>Sensory neurons</topic><topic>Skin</topic><topic>small fiber testing</topic><topic>Standardization</topic><topic>Sympathetic nervous system</topic><topic>Transthyretin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berard, Nicolas</creatorcontrib><creatorcontrib>Verschueren, Annie</creatorcontrib><creatorcontrib>Fortanier, Etienne</creatorcontrib><creatorcontrib>Grapperon, Aude‐Marie</creatorcontrib><creatorcontrib>Kouton, Ludivine</creatorcontrib><creatorcontrib>Rebouh, Hadia</creatorcontrib><creatorcontrib>Gallard, Julien</creatorcontrib><creatorcontrib>Salort‐Campana, Emmanuelle</creatorcontrib><creatorcontrib>Attarian, Shahram</creatorcontrib><creatorcontrib>Delmont, Emilien</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Muscle & nerve</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berard, Nicolas</au><au>Verschueren, Annie</au><au>Fortanier, Etienne</au><au>Grapperon, Aude‐Marie</au><au>Kouton, Ludivine</au><au>Rebouh, Hadia</au><au>Gallard, Julien</au><au>Salort‐Campana, Emmanuelle</au><au>Attarian, Shahram</au><au>Delmont, Emilien</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers</atitle><jtitle>Muscle & nerve</jtitle><addtitle>Muscle Nerve</addtitle><date>2025-02</date><risdate>2025</risdate><volume>71</volume><issue>2</issue><spage>208</spage><epage>215</epage><pages>208-215</pages><issn>0148-639X</issn><issn>1097-4598</issn><eissn>1097-4598</eissn><abstract>ABSTRACT
Introduction/Aims
It is imperative to screen asymptomatic carriers of transthyretin (TTR) mutations to initiate treatment early. The protocol for repeated electrodiagnostic (EDX) assessments over time lacks standardization. Our aim was to report the electrophysiological evolution of a cohort of asymptomatic carriers and to determine which biomarkers were most sensitive to change.
Methods
We performed a retrospective review of medical records of asymptomatic carriers identified by screening families with amyloid neuropathy. Carriers who underwent two EDX assessments with a minimum 1‐year interval between studies were selected. EDX included analysis of median, ulnar, tibial, fibular and sural nerves, motor unit number index (MUNIX), electrochemical skin conductance, sympathetic skin response, and heart rate variability on deep breathing. Measurements were compared at first and second examinations.
Results
Twenty‐three carriers were included with a median age of 49 years (interquartile range 37–58). Median time between examinations was 3 years (2–4). Compound muscle and sensory nerve action potential (CMAP and SNAP) amplitudes, nerve conduction velocities, autonomic small fiber testing and MUNIX remained stable except for motor distal latency of the median nerve (+0.07 ms/year) and CMAP duration of the ulnar (+0.10 ms/year) and fibular (+0.12 ms/year) nerves. The CMAP duration of the ulnar nerve was the most sensitive biomarker to change when performed within 10 years preceding the age of the youngest case in the family, with a standardized response mean of 0.91.
Discussion
Nerve conduction parameters remain relatively stable in asymptomatic TTR carriers. Changes can only be detected using multimodal and extensive electrophysiological tests.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>39668650</pmid><doi>10.1002/mus.28318</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5591-2774</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0148-639X |
ispartof | Muscle & nerve, 2025-02, Vol.71 (2), p.208-215 |
issn | 0148-639X 1097-4598 1097-4598 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11708451 |
source | Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list) |
subjects | Action potential Action Potentials - physiology Adult Amyloid Neuropathies, Familial - diagnosis Amyloid Neuropathies, Familial - genetics Amyloid Neuropathies, Familial - physiopathology Assessments Asymptomatic asymptomatic carriers Autonomic nervous system Biomarkers Clinical Electrochemistry Electrodiagnosis - methods electrophysiological monitoring familial amyloid polyneuropathy Female Heart rate Heterozygote Humans Latency Male Median nerve Medical records Middle Aged Mutation Nerve conduction Neural Conduction - physiology Neuropathy Parameter sensitivity Prealbumin - genetics Retrospective Studies Sensory neurons Skin small fiber testing Standardization Sympathetic nervous system Transthyretin |
title | Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T23%3A22%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Electrophysiological%20Monitoring%20of%20Asymptomatic%20Transthyretin%20Mutation%20Carriers&rft.jtitle=Muscle%20&%20nerve&rft.au=Berard,%20Nicolas&rft.date=2025-02&rft.volume=71&rft.issue=2&rft.spage=208&rft.epage=215&rft.pages=208-215&rft.issn=0148-639X&rft.eissn=1097-4598&rft_id=info:doi/10.1002/mus.28318&rft_dat=%3Cproquest_pubme%3E3152517341%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3348-e7be3ba3c54f819fd2579d3c4df1409a91fc41cd8cca34dbb53978f3155676f93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3152517341&rft_id=info:pmid/39668650&rfr_iscdi=true |